DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.505
-0.035 (-0.99%)
Apr 21, 2025, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $150.21 million as of April 21, 2025. Its market cap has increased by 41.31% in one year.
Market Cap
150.21M
Enterprise Value
107.90M
1-Year Change
41.31%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $150.21M, an increase of 309.29%. That is a compound annual growth rate of 24.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 151.70M | -34.67% |
Dec 31, 2024 | 232.20M | 115.40% |
Dec 29, 2023 | 107.80M | 157.89% |
Dec 30, 2022 | 41.80M | -57.61% |
Dec 31, 2021 | 98.60M | -48.11% |
Dec 31, 2020 | 190.00M | 226.46% |
Dec 31, 2019 | 58.20M | 68.70% |
Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 754.27B |
UnitedHealth Group | 415.38B |
Johnson & Johnson | 379.48B |
AbbVie | 306.02B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 227.16B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |